Published within
|«
«
|
...
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
ResearchWire
|
Published By Datamonitor
|
21 Jul 2006 |
|
Expert View
|
Branded antibacterials had best beware: the antibacterial market is currently best described as saturated, highly segmented and increasingly flooded with generics. Furthermore, bacterial drug-resistance is threatening currently marketed drugs, although this represents an opportunity for the more audacious drug maker.
Published By Datamonitor
|
19 Aug 2005 |
|
CommentWire
|
A new study has reported a substantial decrease in pediatric antibiotic prescriptions between 1996 and 2000. The development shows the success of a wider campaign to reduce overuse of antibiotics - a serious problem that contributes to the development of disease-resistant forms of common bacteria.
Published By Datamonitor
|
04 Sep 2003 |
|
CommentWire
|
The Food and Drug Administration (FDA) is set to examine the potential link between antidepressants and increased suicidal tendencies in adults. Even if the FDA finds such a link however, the likely outcome will be proposals for more 'black box' labels and its ultimate impact on antidepressant revenues will be relatively slight.
Published By Datamonitor
|
01 Oct 2004 |
|
ResearchWire
|
Published By Datamonitor
|
09 Feb 2006 |
|
ResearchWire
|
Published By Datamonitor
|
17 Feb 2006 |
|
CommentWire
|
Antigenics' [AGEN] most advanced pipeline treatment, Oncophage, is showing promising phase II activity where the vaccine has been shown to stimulate the body's immune cells. Currently no vaccines are approved for the treatment of cancer in the seven major markets, creating a lucrative investment opportunity in the coming years, but physician reservations will need to be overcome.
Published By Datamonitor
|
06 Oct 2003 |
|
ResearchWire
|
Published By Datamonitor
|
27 Mar 2006 |
|
ResearchWire
|
Published By Datamonitor
|
08 Apr 2005 |
|
ResearchWire
|
Published By Datamonitor
|
03 May 2006 |
|
|«
«
|
...
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.